Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Investor profile

Versant Ventures

Venture capital firm · Founded 1999 · Active in 2026

Versant Ventures is a venture capital firm based in USA, founded in 1999. The page below shows 27 Power Law outcomes from Versant Ventures's portfolio — 22 unicorns ($1B+ valuation) and 4 additional thoroughbreds (companies that crossed $100M+ in revenue without yet reaching $1B+ valuation).

Outcomes are concentrated in Biotech & Life Sciences · eCommerce & Marketplaces; top portfolio geographies are USA · Switzerland · Ireland. Versant ranks #345 in Global in the 2026 Dealroom Power Law Investor Ranking by cross-stage outcomes.

27 Power Law outcomes Power Law Ranking #345 · Global · 27 Power Law outcomes · Active 2026
Unicorns ↑ 22% 5y
22
Decacorns → 0% 5y
2
Thoroughbreds ↓ 18% 5y
12
01 · Exits

Versant’s biggest exits.

Versant portfolio companies worth $1B+ that have IPO’d or been acquired. Each shows its valuation at exit and, in grey, its current value if still public.

IPO · 2007
Entered Series ANow $17.6B
IPO · 2007
Entered Series B+Now $11.2B
IPO · 2015
Entered Series ANow $6.9B
$1.0B IPO · 2020
Entered Series ANow $4.9B
$4.7B IPO · 2021
Entered Series B+Now $1.6B
$4.1B IPO · 2023
Entered Series ANow $3.7B
$4.0B IPO · 2021
Entered Series B+Now $1.4B
$433M IPO · 2019
Entered Series ANow $3.8B
$626M IPO · 2016
Entered Series ANow $3.2B
IPO · 2013
Entered Series B+Now $3.2B
$391M IPO · 2018
Entered Series ANow $2.6B
IPO · 2013
Entered Series B+Now $1.9B
$513M IPO · 2020
Entered Series ANow $1.9B
$1.5B acquisition · 2021
Entered Series A
IPO · 2014
Entered Series B+Now $1.2B
$1.1B acquisition · 2024
Entered Series A
$1.0B acquisition · 2019
Entered Series A
$24M IPO · 2021
Entered Series ANow $1.0B
03 · Portfolio analysis

The 27 Versant Power Law outcomes ($100M+ revenue or $1B+ valuation).

Snapshot of where the outcomes are concentrated by country, sector, and stage entered.

By countryCount
  1. USA23
  2. Switzerland2
  3. Ireland1
  4. Canada1
By sectorCount
  1. Biotech & Life Sciences26
  2. eCommerce & Marketplaces1
By stage enteredCount
  1. Series B+8
  2. Series A17
  3. Seed1
04 · Portfolio market map

Versant's 27 Power Law outcomes.

Stage entered
Outcome tier
Region
Group by
27 of 27 Power Law outcomes
05 · Power Law comparison

How does Versant stack up?

Versant in orange, your selection in blue and other colours. Pick from the global roster of 609 peer investors — scope by startup location or hit "Find similar shapes" to auto-pick the three closest. The funnel matrix mirrors the spider chart on the ranking page; the line chart shows each firm's share of unicorns minted in the selected startup location — peaks reveal vintage years.

Compare against

Share of new unicorns per year

% of global unicorns minted that year, year by year · hover the chart to see which unicorns
Performance window All-time → 2026

Stage focus

Companies by selected outcome stage

Sector focus

Companies per investor across the 10 highest-volume sectors

Beyond Unicorns — how the portfolio compounds

% of each investor's unicorn portfolio that later crossed $10B, $25B and $50B. Pick a sort tier and entry stage.
Sort by
Entry stage
Source: Dealroom Power Law dataset. Investors shown are the 2026 Power Law top 35 by combined entry-to-outcome score, drawn from the overview and locations_data sheets. Funnel-matrix axes rescale per-axis using the maximum among the currently selected investors, so the polygons always fill the chart for shape comparison.
06 · Portfolio founders

Where Versant's portfolio founders come from — and where they studied.

7 founders across the 27 Power Law outcomes — split by country of origin, university attended, and the company they worked at before founding. Harvard University and Five Prime Therapeutics are the deepest single pipelines.

LocationCount
United States7
View on app →
UniversityCount
Harvard University1
University of Michigan Ross School of Business1
Bowdoin College1
Washington University in St. Louis1
Xavier University1
View on app →
Origin companyCount
Five Prime Therapeutics2
Nektar Therapeutics1
Amicus Therapeutics1
BioMarin Pharmaceutical1
View on app →
Origin = country a founder is born in or grew up in (founders may have multiple origins; counts include all entries). University = highest-listed degree. Origin company = a previous employer where the founder was tagged before starting their current company.

Market sentiment

What the market is saying about Versant Ventures

An AI-synthesized read of the highest-engagement posts about Versant on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

In the news

Latest news about Versant Ventures

Recent press, funding announcements, and portfolio moves mentioning Versant — pulled live from Dealroom's news feed.

See all news

Want the full picture on Versant Ventures?

The Dealroom platform tracks every round, every co-investor, and every portfolio company in real time — across 25,000+ investors and 3M+ companies globally.